Organic Chemistry TRIZ Cases

Graded cesium concentrations in the catalyst bed balance selectivity and activity across varying reaction conditions, improving overall production efficiency.

A blue phosphorescence compound with a dibenzofuran core serves as the host material in organic light emitting diodes.

Non-peptide prokineticin receptor antagonists block PK-R1 and PK-R2 signaling to shift Th1 to Th2 cytokine profiles, reducing multiple sclerosis severity.

Benzimidazole and carbazole derivatives form bipolar host materials that enable high luminous efficiency in organic light-emitting diodes.

Doped aromatic amine-terphenyl compounds resolve conductivity-stability trade-offs by enhancing charge carrier movability while maintaining thermal resilience.

Optimized fluorination patterns shorten diffusion lengths, resolving the trade-off between acid strength and lithographic resolution.

Thioxanthone aromatic amine compounds resolve stability trade-offs by providing single structure, determinate molecular weight, and better solubility.

Dual-layer resist process forms thin metal film patterns via acid-mediated crosslinking, resolving resolution and etching resistance trade-offs.

A quantitative model describes the assembly of diketopyrrolopyrrole donors and perylenediimide acceptors into chiral superstructures.

A lactone compound with specific substituents enhances water stability by suppressing hydrolysis and oxidative decomposition.

Cyanate group polymer composition resolves solvent solubility versus heat resistance trade-offs, enabling finer pattern formation without collapse.

Quinoline compounds modulate SERCA activity to restore endoplasmic reticulum stress homeostasis in neurodegenerative disorders.

A bis-onium salt resist composition enhances sensitivity through integrated acid generation and quenching.

Episulfide optical composition stabilizes storage while maintaining light resistance.

Quinazolinyl compounds inhibit IRE1α kinase and endoribonuclease activities to drive tumor cell apoptosis.

A phenanthrene compound serves as a host in organic light emitting devices to facilitate efficient electron injection and exciton management.

Conjugated diene compounds create thermally stable solid electrolyte interfaces that prevent cracking during high temperature storage.

A purification process for an AXL tyrosine kinase inhibitor free base uses a mixed alcohol-water solvent system to precipitate the compound.

Isoxazolo-pyridazine derivatives selectively bind the GABA A α5 receptor to enhance cognition while eliminating proconvulsant activity.

Saponification converts lutein esters to free lutein, enabling high yield extraction at low temperatures that prevent xanthophyll degradation.

A UV curable resin composition combines modified epoxy acrylate and urethane acrylate oligomers to form a transparent coating film on steel sheets.

CRM1 inhibitors resolve chronic inflammation by accelerating wound healing through enhanced scab formation.

Cleavable linkers enable in vivo activation of PROTAC degraders to overcome inadequate existing treatments.

Electrochemical dehalogenation of waste PVC generates reactive halogen species for organic synthesis, eliminating hazardous thermal treatment conditions.

HIF prolyl-4-hydroxylase inhibitors reduce ATF-4 activity and edema, bypassing iron accumulation limits.

Isoindolinone aminopyrimidine compounds selectively inhibit NUAK kinases, blocking YAP/TAZ nuclear localization and attenuating transcriptional function.

A triarylamine compound with bipolar properties manages charge transport in organic light-emitting elements.

Chiral salt formation purifies saroglitazar magnesium, resolving variable purity and stability issues in pharmaceutical synthesis.

Combining Formula 1 and Formula 2 host materials resolves the power efficiency versus device lifetime trade-off in OLED panels.

Dithiolate-grafted gold nanoparticles detect anti-icing activity through color changes during freezing.

Dual heterocycloalkyl antagonists merge CCR2 and CCR5 inhibition into single molecules, reducing drug-drug interactions while maintaining therapeutic efficacy.

A two-stage acidic washing process removes hydrocyanic acid from crude dinitrotoluene mixtures through controlled liquid-liquid extraction.

Substituted pyridine compounds block sodium channels, addressing limited efficacy and side effects of current analgesics.

Solvent-free reactive melt extrusion converts epoxy resins to episulfide resins, eliminating VOC waste and shortening reaction time from hours to seconds.

A photoresist composition uses a specific acid diffusion control agent to manage acid movement during exposure.

Thiazolidinedione derivatives inhibit the 15-hydroxyprostaglandin dehydrogenase enzyme to stabilize prostaglandin E2 activity.

Alpha-diketones replace toxic polycyclic aromatic hydrocarbons to enable safer handling and versatile electron or proton transfer in mass spectrometers.

Pyridoquinazoline derivatives replace inorganic dopants to resolve diffusion issues, enabling sharp p-n transitions while maintaining thermal stability.

A wire-tethered electrode assembly uses a cylindrical body and spear to launch and couple with targets while distributing current density through a spreading structure.

Chromium catalyst mediates stereoselective coupling of poly-halogenated nucleophiles to synthesize C1-C19 and C20-C38 halichondrin building blocks.

DPP-4 inhibitors treat type 2 diabetes in patients with renal impairment or metformin intolerance by switching elimination pathways to hepatic metabolism.

Indenofluorene hole transport materials prevent source clogging during vapor deposition while lowering operating voltage.

Ortho-substituted dehydrogenated fused-ring structures resolve low sublimation yields in p-type doping materials while maintaining charge injection capability.

Specific substituent groups on the pyrrolic amide core enhance antitumor efficacy while reducing toxicity in cancer treatment.

Targeting the myr-CoA pocket diversifies inhibitor structures, reducing resistance risk while maintaining therapeutic efficacy.

N-linked lactam compounds modulate the muscarinic M1 receptor as positive allosteric agents.